Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oceans Omega is a biotechnology company specializing in the development and delivery of water-soluble omega-3 fatty acids for the functional food and beverage markets. As a subsidiary of Mycell Technologies, the company utilizes a proprietary emulsification platform to create stable, clear, and odorless EPA and DHA ingredients. These ingredients allow manufacturers to fortify products such as bottled water, juices, and dairy without the typical sensory challenges associated with fish oils. Their technology focuses on enhancing the bioavailability and shelf-stability of polyunsaturated fatty acids in diverse delivery formats. By addressing the technical challenges of oxidation and solubility, Oceans Omega provides manufacturers with a scalable solution for nutrient enrichment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oceans Omega.